Clinical Lung Cancer : Impact Factor & More
eISSN: 1938-0690pISSN: 1525-7304
Share this on:
Aims and Scope of Clinical Lung Cancer
Clinical Lung Cancer is a peer-reviewed medical journal that has been published by Elsevier since 2011. It was established by the CIG Media Group in 1999.
Key Metrics
CiteScore 
7.5
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q2Oncology
SNIP
1.18
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Clinical Lung Cancer
Clinical Lung Cancer Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | CIG MEDIA GROUP, LP |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Clinical Lung Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Clinical Lung Cancer
Pretreatment SUVmax Stratifies the Benefit of Consecutive Daily SBRT in Early-Stage Non-Small Cell Lung Cancer.
- 8 Jun 2026
- Clinical lung cancer
Outcomes of Platinum Plus Pemetrexed and Treatment Patterns Following First-Line Nivolumab and Ipilimumab in Pleural Mesothelioma: Real-World Results From the German MesoNet Study.
- 6 Jun 2026
- Clinical lung cancer
Erlotinib-Induced Ocular Cicatricial Pemphigoid in EGFR-Mutated Non-Small Cell Lung Cancer: A Case Report.
- 1 Jun 2026
- Clinical lung cancer
Severe Toxic Epidermal Necrolysis Following Combination Ipilimumab-Nivolumab Therapy for Pleural Mesothelioma, Successfully Treated With Ruxolitinib: A Case Report.
- 1 Jun 2026
- Clinical lung cancer
Impact of Immune Checkpoint Inhibitor-Combined Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer With Brain Metastases.
- 1 Jun 2026
- Clinical lung cancer
Staging Modalities in Non-Small Cell Lung Cancer: Evidence-Based Guideline and Systematic Review by the Brazilian Group of Thoracic Oncology.
- 1 Jun 2026
- Clinical lung cancer
Pretreatment SUVmax Stratifies the Benefit of Consecutive Daily SBRT in Early-Stage Non-Small Cell Lung Cancer.
- 8 Jun 2026
- Clinical lung cancer
Outcomes of Platinum Plus Pemetrexed and Treatment Patterns Following First-Line Nivolumab and Ipilimumab in Pleural Mesothelioma: Real-World Results From the German MesoNet Study.
- 6 Jun 2026
- Clinical lung cancer
Erlotinib-Induced Ocular Cicatricial Pemphigoid in EGFR-Mutated Non-Small Cell Lung Cancer: A Case Report.
- 1 Jun 2026
- Clinical lung cancer
Severe Toxic Epidermal Necrolysis Following Combination Ipilimumab-Nivolumab Therapy for Pleural Mesothelioma, Successfully Treated With Ruxolitinib: A Case Report.
- 1 Jun 2026
- Clinical lung cancer
Impact of Immune Checkpoint Inhibitor-Combined Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer With Brain Metastases.
- 1 Jun 2026
- Clinical lung cancer
Staging Modalities in Non-Small Cell Lung Cancer: Evidence-Based Guideline and Systematic Review by the Brazilian Group of Thoracic Oncology.
- 1 Jun 2026
- Clinical lung cancer
FAQs on Clinical Lung Cancer
How long has Clinical Lung Cancer been actively publishing? 
What is the publishing frequency of Clinical Lung Cancer?
How many articles did Clinical Lung Cancer publish last year?
What is the eISSN & pISSN for Clinical Lung Cancer?
What is Citescore for Clinical Lung Cancer?
What is SNIP score for Clinical Lung Cancer?
What is the SJR for Clinical Lung Cancer?
Who is the publisher of Clinical Lung Cancer?
